Literature DB >> 24132607

Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis.

Wei Dai1, Qing Zhou, Zhongfei Xu, Enjiao Zhang.   

Abstract

Although there is growing evidence supporting the hypothesis that TMPRSS4 is linked with cancer susceptibility, the precise role of TMPRSS4 expression in salivary adenoid cystic carcinoma (SACC) is still unknown. The aim of this study was to examine TMPRSS4 expression in SACC and determine its associations with clinicopathological features and survival. TMPRSS4 expression in 125 SACC tissue and adjacent non-cancerous tissues was analyzed by immunohistochemistry and Western blotting. In addition, the correlation of TMPRSS4 expression with clinicopathological variables was evaluated. The prognostic value of TMPRSS4 for overall survival (OS) and disease-free survival (DFS) was determined by Kaplan-Meier estimates, and the significance of differences between curves was evaluated by the log-rank test. We found that high TMPRSS4 expression was predominantly observed in SACC tissues, but not in the adjacent normal salivary gland tissues. High TMPRSS4 expression in SACC tissues was correlated significantly with tumor TNM stage (P = 0.016), lymph node metastasis (P = 0.002) and distant metastasis (P < 0.001). While high TMPRSS4 expression was associated with poor OS (P = 0.019) and DFS (P = 0.031), Cox regression analysis also revealed that TMPRSS4 was an independent predictor of OS and DFS. These findings suggested that TMPRSS4 was involved in the pathogenesis of SACC and might indicate a poor prognosis for SACC patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132607     DOI: 10.1007/s12032-013-0749-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition.

Authors:  T Li; Z-C Zeng; L Wang; S-J Qiu; J-W Zhou; X-T Zhi; H-H Yu; Z-Y Tang
Journal:  Cancer Gene Ther       Date:  2011-06-03       Impact factor: 5.987

2.  Epithelial-mesenchymal transitions and hepatocarcinogenesis.

Authors:  Janice Jou; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 3.  Adenoid cystic carcinoma: a retrospective clinical review.

Authors:  A J Khan; M P DiGiovanna; D A Ross; C T Sasaki; D Carter; Y H Son; B G Haffty
Journal:  Int J Cancer       Date:  2001-06-20       Impact factor: 7.396

Review 4.  Epithelial-mesenchymal transition in gastric cancer (Review).

Authors:  Masaru Katoh
Journal:  Int J Oncol       Date:  2005-12       Impact factor: 5.650

5.  Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.

Authors:  Jian-Hong Zuo; Wei Zhu; Mao-Yu Li; Xin-Hui Li; Hong Yi; Gu-Qing Zeng; Xun-Xun Wan; Qiu-Yan He; Jian-Huang Li; Jia-Quan Qu; Yu Chen; Zhi-Qiang Xiao
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

6.  Prognostic value of TMPRSS4 expression in patients with breast cancer.

Authors:  Bin Liang; Mingzhe Wu; Yuehua Bu; Ainong Zhao; Fang Xie
Journal:  Med Oncol       Date:  2013-02-19       Impact factor: 3.064

7.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.

Authors:  Henry F Frierson; Adel K El-Naggar; John B Welsh; Lisa M Sapinoso; Andrew I Su; Jun Cheng; Takashi Saku; Christopher A Moskaluk; Garret M Hampton
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.

Authors:  L Larzabal; P A Nguewa; R Pio; D Blanco; B Sanchez; M J Rodríguez; M J Pajares; R Catena; L M Montuenga; A Calvo
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

9.  The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer.

Authors:  Zu-Yan Luo; Yuan-Yu Wang; Zhong-Sheng Zhao; Bo Li; Jun-Fa Chen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.

Authors:  Priya Balasubramanian; James C Lang; Kris R Jatana; Brandon Miller; Enver Ozer; Mathew Old; David E Schuller; Amit Agrawal; Theodoros N Teknos; Thomas A Summers; Maryam B Lustberg; Maciej Zborowski; Jeffrey J Chalmers
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more
  5 in total

1.  Distant Metastases in Patients with Carcinoma of the Major Salivary Glands.

Authors:  Safina Ali; Robert Bryant; Frank L Palmer; Monica DiLorenzo; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-03-06       Impact factor: 5.344

Review 2.  TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.

Authors:  Ping Zeng; Peng Zhang; Li-Na Zhou; Min Tang; Yi-Xin Shen; Jun Jin; Ya-Qun Zhu; Min-Bin Chen
Journal:  Oncotarget       Date:  2016-11-15

3.  TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway.

Authors:  Jianyou Gu; Wenjie Huang; Junfeng Zhang; Xianxing Wang; Tian Tao; Ludi Yang; Yao Zheng; Songsong Liu; Jiali Yang; Liwei Zhu; Huaizhi Wang; Yingfang Fan
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

4.  Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4.

Authors:  Anna Keppner; Ditte Andreasen; Anne-Marie Mérillat; Julie Bapst; Camille Ansermet; Qing Wang; Marc Maillard; Sumedha Malsure; Antoine Nobile; Edith Hummler
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 5.  TMPRSS4: an emerging potential therapeutic target in cancer.

Authors:  A L de Aberasturi; A Calvo
Journal:  Br J Cancer       Date:  2014-09-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.